These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1072 related articles for article (PubMed ID: 16525674)
1. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer. Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674 [TBL] [Abstract][Full Text] [Related]
2. Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis. Inokuchi M; Uetake H; Shirota Y; Yamada H; Tajima M; Sugihara K Cancer Chemother Pharmacol; 2004 May; 53(5):391-6. PubMed ID: 15060742 [TBL] [Abstract][Full Text] [Related]
3. Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer. Okumura K; Mekata E; Shiomi H; Naitoh H; Abe H; Endo Y; Kurumi Y; Tani T Cancer Chemother Pharmacol; 2008 Apr; 61(4):587-94. PubMed ID: 17520254 [TBL] [Abstract][Full Text] [Related]
4. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy. Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211 [TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil-related gene expression in primary sites and hepatic metastases of colorectal carcinomas. Sameshima S; Tomozawa S; Kojima M; Koketsu S; Motegi K; Horikoshi H; Okada T; Kon Y; Sawada T Anticancer Res; 2008; 28(3A):1477-81. PubMed ID: 18630501 [TBL] [Abstract][Full Text] [Related]
6. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Salonga D; Danenberg KD; Johnson M; Metzger R; Groshen S; Tsao-Wei DD; Lenz HJ; Leichman CG; Leichman L; Diasio RB; Danenberg PV Clin Cancer Res; 2000 Apr; 6(4):1322-7. PubMed ID: 10778957 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy. Yamada H; Iinuma H; Watanabe T Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408 [TBL] [Abstract][Full Text] [Related]
8. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C Oncology; 2006; 70(5):366-77. PubMed ID: 17179731 [TBL] [Abstract][Full Text] [Related]
9. 5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis. Kuramochi H; Hayashi K; Uchida K; Miyakura S; Shimizu D; Vallbohmer D; Park S; Danenberg KD; Takasaki K; Danenberg PV Int J Cancer; 2006 Aug; 119(3):522-6. PubMed ID: 16572420 [TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil-related gene expression in hepatic artery infusion-treated patients with hepatic metastases from colorectal carcinomas. Sameshima S; Tomozawa S; Horikoshi H; Motegi K; Hirayama I; Koketsu S; Okada T; Kojima M; Kon Y; Sawada T Anticancer Res; 2008; 28(1B):389-93. PubMed ID: 18383874 [TBL] [Abstract][Full Text] [Related]
11. Thymidine phosphorylase mRNA level predicts survival of patients with advanced oropharyngeal cancer. Ijuin T; Nibu K; Doi K; Inoue H; Saitoh M; Ohtsuki N; Makino K; Amatsu M Acta Otolaryngol; 2007 Mar; 127(3):305-11. PubMed ID: 17364369 [TBL] [Abstract][Full Text] [Related]
12. Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer. Fakhrejahani E; Miyamoto A; Tanigawa N Cancer Chemother Pharmacol; 2007 Aug; 60(3):437-46. PubMed ID: 17377791 [TBL] [Abstract][Full Text] [Related]
13. [Expression of dihydropyrimidine dehydrogenase in primary colorectal cancer and liver metastasis--a relationship between mRNA levels in cancer cells and protein levels in cancerous tissue and effect of 5-fluorouracil]. Ishibashi K; Sobajima J; Ishiguro T; Ohsawa T; Okada N; Miyazaki T; Yokoyama M; Inokuma S; Ishida H Gan To Kagaku Ryoho; 2009 Nov; 36(12):2232-5. PubMed ID: 20037380 [TBL] [Abstract][Full Text] [Related]
14. TS and DPD mRNA levels on formalin-fixed paraffin-embedded specimens as predictors for distant recurrence of rectal cancer treated with preoperative chemoradiotherapy. Tanaka K; Saigusa S; Toiyama Y; Koike Y; Okugawa Y; Yokoe T; Inoue Y; Kobayashi M; Miki C; Kusunoki M J Surg Oncol; 2012 May; 105(6):529-34. PubMed ID: 22006578 [TBL] [Abstract][Full Text] [Related]
15. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test. Kakimoto M; Uetake H; Osanai T; Shirota Y; Takagi Y; Takeshita E; Toriya Y; Danenberg K; Danenberg PV; Sugihara K Cancer Lett; 2005 Jun; 223(1):103-11. PubMed ID: 15890242 [TBL] [Abstract][Full Text] [Related]
16. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase]. Ishida H; Yamada H; Shirakawa K; Nakada H; Ohsawa T; Takeuchi I; Okada N; Yokoyama M; Inokuma S; Suzuki T; Odaka A; Hoshino T; Murata N; Hashimoto D; Itoyama S; Mori T; Matsumoto Y; Miura T Gan To Kagaku Ryoho; 2003 Oct; 30(11):1621-6. PubMed ID: 14619479 [TBL] [Abstract][Full Text] [Related]
17. Relationship between gene expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in primary cancer cells isolated from malignant ascites. Wang T; Wang L; Qian X; Yu L; Ding Y; Liu B Cancer Invest; 2011 Feb; 29(2):130-6. PubMed ID: 21210725 [TBL] [Abstract][Full Text] [Related]
18. Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis. Kobayashi H; Sugihara K; Uetake H; Higuchi T; Yasuno M; Enomoto M; Iida S; Azuma M; Mori R; Omori A; Lenz HJ; Danenberg KD; Danenberg PV Int J Oncol; 2008 Dec; 33(6):1257-62. PubMed ID: 19020759 [TBL] [Abstract][Full Text] [Related]
19. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer. Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876 [TBL] [Abstract][Full Text] [Related]
20. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. Ichikawa W; Uetake H; Shirota Y; Yamada H; Nishi N; Nihei Z; Sugihara K; Hirayama R Clin Cancer Res; 2003 Feb; 9(2):786-91. PubMed ID: 12576451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]